Report post

What is Cellectis SA (clls)?

The company's mission is to develop a new generation of cancer therapies based on engineered T-cells. Stock analysis for Cellectis SA (CLLS:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

Why did Cellectis stock rocket 179 3% in premarket trading?

The U.S.-listed shares of Cellectis S.A. CLLS rocketed 179.3% on very heavy volume in premarket trading Wednesday, after the France-based biotechnology company announced an equity investment of $220 m...

Is Cellectis a publicly traded company?

Cellectis became a publicly traded company in 2007, and raised €21.2 million in a stock offering on Euronext. In 2010, it acquired Cyto Pulse, which had developed a new electroporation technology, and in 2011 it paid €28 million for Cellartis, a Swedish biotechnology company.

The World's Leading Crypto Trading Platform

Get my welcome gifts